MRES

 
Common Stock Dark or Defunct
Pink No Information
Contact Info
  • Institute of BioMedical Research
  • Ljubljanska bb,
  • Podgorica 81000
  • Montenegro

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Mar 29, 2013
Audited Financials Unaudited
Latest Report Jun 30, 2015 Quarterly Report
CIK 0000894561
Fiscal Year End 3/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 8071 - Medical laboratories
Incorporated In: NV, USA
Year of Inc. 1990
Employees 26 a/o May 07, 2014
Company Officers/Contacts
Drasko Pekovic President, CEO
Company Directors
Drasko Pekovic
Service Providers
Accounting/Auditing Firm
KBL, LLP
114 West 47th Street, 19th Floor
Suite 1900
New York, NY, 10036
United States
 
Securities Counsel
Stephen A. Zrenda Jr. Esq.
12313 Hidden Forest Blvd
Oklahoma City, OK, 73142
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Neuro-Biotech Corp. until 4-2014
  • Formerly=M45 Mining Resources, Inc. until 6-2010
  • Formerly=Quantitative Methods Corp. until 4-07
MRES Security Details
Share Structure
Market Value1 $507,768 a/o Jun 26, 2017
Authorized Shares 2,000,000,000 a/o Dec 31, 2014
Outstanding Shares 846,280,777 a/o Dec 31, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 344,995,907 a/o Sep 05, 2014
Par Value 0.001
Shareholders
Shareholders of Record 515 a/o Sep 05, 2014
Short Selling Data
Short Interest 263,500 (100%)
Apr 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security